Precision BioSciences, Inc. Profile Avatar - Palmy Investing

Precision BioSciences, Inc.

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides…

Biotechnology
US, Durham [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of DTIL's Analysis
CIK: 1357874 CUSIP: 74019P108 ISIN: US74019P2074 LEI: - UEI: -
Secondary Listings
DTIL has no secondary listings inside our databases.